or Try an Advanced Search...

    Technical Analysis for VRAX - Virax Biolabs Group Limited

    Grade Last Price % Change Price Change
    D 1.88 0.00% 0.00
    VRAX closed down 2.08 percent on Wednesday, November 20, 2024, on 6 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical VRAX trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish -2.08%
    Inside Day Range Contraction -2.08%
    Wide Bands Range Expansion -2.08%
    Oversold Stochastic Weakness -2.08%
    Pocket Pivot Bullish Swing Setup 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Older End-of-Day Signals for VRAX ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout 44 minutes ago
    Up 1% 44 minutes ago
    Down 3% about 3 hours ago
    60 Minute Opening Range Breakdown about 3 hours ago
    Down 2 % about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    VRAX Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Virax Biolabs Group Limited is an innovative biotechnology group focused on the detection and diagnosis of viral diseases, with a particular interest in the field of immunology. Virax Biolabs Group Limited is currently developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Clinical Medicine Immunology Hepatitis B Hepatitis Virus Malaria Viral Disease Herpes Herpes Simplex Monkeypox

    Is VRAX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 23 Top Midday Gainers
    Oct 23 Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
    Oct 23 EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland
    Sep 16 Virax Biolabs extends distribution agreement to market Mpox detection kits
    Sep 16 Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
    Sep 9 Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference
    Sep 5 Singapore announces quarantine measures for close contacts of mpox infected patients
    Aug 29 Virax Biolabs to Participate at 7th European Congress of Immunology
    Aug 28 Virax stock rallies 22% on mpox detection kit deal
    Aug 28 What's Going On With Virax Biolabs Stock Wednesday
    See more VRAX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.9999
    52 Week Low 0.6
    Average Volume 2,517,936
    200-Day Moving Average 1.56
    50-Day Moving Average 2.04
    20-Day Moving Average 2.07
    10-Day Moving Average 1.99
    Average True Range 0.27
    RSI (14) 45.65
    ADX 29.11
    +DI 28.98
    -DI 16.38
    Chandelier Exit (Long, 3 ATRs) 2.81
    Chandelier Exit (Short, 3 ATRs) 2.47
    Upper Bollinger Bands 2.46
    Lower Bollinger Band 1.69
    Percent B (%b) 0.25
    BandWidth 36.99
    MACD Line -0.06
    MACD Signal Line -0.04
    MACD Histogram -0.0142
    Fundamentals Value
    Market Cap 4.44 Million
    Num Shares 2.36 Million
    EPS -17.70
    Price-to-Earnings (P/E) Ratio -0.11
    Price-to-Sales 25.14
    Price-to-Book 0.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.12
    Resistance 3 (R3) 2.13 2.05 2.08
    Resistance 2 (R2) 2.05 1.99 2.05 2.07
    Resistance 1 (R1) 1.97 1.95 1.93 1.96 2.05
    Pivot Point 1.89 1.89 1.88 1.89 1.89
    Support 1 (S1) 1.81 1.83 1.77 1.80 1.71
    Support 2 (S2) 1.73 1.79 1.73 1.69
    Support 3 (S3) 1.65 1.73 1.68
    Support 4 (S4) 1.64